Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Advaxis Inc (ADXS)  
$0.06 0.00 (0.00%) as of 4:30 Fri 6/3


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 66,230,000
Market Cap: 4.11(M)
Last Volume: 362,100 Avg Vol: 361,089
52 Week Range: $0.062 - $0.062
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,317,716 1,317,716
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 465
  Page 6 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bonstein Sara Chief Financial Officer   •       –      –    2016-09-30 4 D $10.69 $460 D/D (43) 81,577     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-09-30 4 A $10.69 $2,042 D/D 191 81,620     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-09-30 4 D $10.69 $535 D/D (50) 302,660     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-09-30 4 A $10.69 $3,784 D/D 354 302,710     -
   Mayes Gregory T. Chief Business Officer   •       •      –    2016-09-30 4 D $10.69 $481 D/D (45) 122,249     -
   Mayes Gregory T. Chief Business Officer   •       •      –    2016-09-30 4 A $10.69 $2,181 D/D 204 122,294     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-08-31 4 D $11.53 $530 D/D (46) 302,356     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-08-31 4 A $11.53 $3,782 D/D 328 302,402     -
   Mayes Gregory T. Chief Operating Officer   •       •      –    2016-08-31 4 D $11.53 $484 D/D (42) 122,090     -
   Mayes Gregory T. Chief Operating Officer   •       •      –    2016-08-31 4 A $11.53 $2,191 D/D 190 122,132     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-08-31 4 D $11.53 $334 D/D (29) 123,197     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-08-31 4 A $11.53 $2,271 D/D 197 123,226     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-08-31 4 D $11.53 $461 D/D (40) 81,429     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-08-31 4 A $11.53 $2,041 D/D 177 81,469     -
   Sidransky David Director   –       •      –    2016-08-09 4 S $14.85 $169,349 D/D (11,404) 80,355     -
   Berman Richard J Director   –       •      –    2016-08-09 4 S $15.67 $246,975 D/D (15,761) 50,669     -
   Sidransky David Director   –       •      –    2016-08-08 4 S $15.17 $172,999 D/D (11,404) 91,759     -
   Berman Richard J Director   –       •      –    2016-08-08 4 S $15.21 $273,780 D/D (18,000) 66,430     -
   Mayes Gregory T. Chief Operating Officer   •       •      –    2016-07-29 4 D $8.34 $484 D/D (58) 121,942     -
   Mayes Gregory T. Chief Operating Officer   •       •      –    2016-07-29 4 A $8.34 $2,185 D/D 262 122,000     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-07-29 4 D $8.34 $4,687 D/D (562) 310,341     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-07-29 4 A $8.34 $9,449 D/D 1,133 310,903     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-07-29 4 D $8.34 $959 D/D (115) 125,834     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-07-29 4 A $8.34 $2,277 D/D 273 125,949     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-07-29 4 D $8.34 $450 D/D (54) 81,292     -

  465 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed